Currently holds positions in Bausch & Lomb Inc, Amgen Inc and Precigen Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Bausch & Lomb Inc | March 1, 2010 - |
Independent Director | Amgen Inc | July 30, 2015 - |
Independent Director | Precigen Inc | June 30, 2016 - |
Director | Bausch Health Companies Inc | Aug. 7, 2013 - May 20, 2014 |
Non-Executive Chairman of the Board | Avon Products Inc | Jan. 1, 2013 - April 26, 2013 |
Lead Independent Director | Avon Products Inc | Feb. 1, 2009 - Jan. 1, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-16 | 2023-08-14 |
Precigen Inc
(PGEN)
|
B Purchase |
570,345
+184.8%
1.75998,104 USD |
570,345 +184.8% | 1.75 | 998,104 USD | |
2022-01-03 | 2021-12-29 |
BridgeBio Pharma Inc
(BBIO)
|
B Purchase |
19,300
+inf%
14.17273,390 USD |
19,300 +inf% | 14.17 | 273,390 USD | |
2013-09-03 | 2013-08-29 | B Purchase |
51,000
+1717.8%
99.015,049,459 USD |
51,000 +1717.8% | 99.01 | 5,049,459 USD | ||
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
7,400
+1.0%
18.29135,346 USD |
7,400 +1.0% | 18.29 | 135,346 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
11,470
+1.6%
18.28209,672 USD |
11,470 +1.6% | 18.28 | 209,672 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
50,730
+7.8%
18.27926,837 USD |
50,730 +7.8% | 18.27 | 926,837 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
15,800
+2.5%
18.26288,508 USD |
15,800 +2.5% | 18.26 | 288,508 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
4,600
+0.7%
18.2583,950 USD |
4,600 +0.7% | 18.25 | 83,950 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
4,500
+0.7%
18.2482,080 USD |
4,500 +0.7% | 18.24 | 82,080 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
2,100
+0.3%
18.2338,283 USD |
2,100 +0.3% | 18.23 | 38,283 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
8,400
+1.4%
18.22153,048 USD |
8,400 +1.4% | 18.22 | 153,048 USD | |
2008-04-24 | 2008-04-24 |
Merck & Co Inc
(MRK)
|
B Purchase |
5,000
+0.8%
18.2191,050 USD |
5,000 +0.8% | 18.21 | 91,050 USD |